Suplatast and asthma

NEW YORK, July 24 (Praxis Press) Th2 cytokines are strongly implicated in the immunopathology of asthma. Tamaoki and colleagues evaluated the steroid-sparing effect of suplatast tosilate, a selective Th2 cytokine inhibitor, relative to placebo in patients with steroid-dependent asthma. When steroid doses were halved, patients in the suplatast tosilate group had less deterioration of pulmonary function, asthma symptoms, and reliance on beta2-agonists for relief. These benefits were achieved with

July 25, 2000

NEW YORK, July 24 (Praxis Press) Th2 cytokines are strongly implicated in the immunopathology of asthma. Tamaoki and colleagues evaluated the steroid-sparing effect of suplatast tosilate, a selective Th2 cytokine inhibitor, relative to placebo in patients with steroid-dependent asthma. When steroid doses were halved, patients in the suplatast tosilate group had less deterioration of pulmonary function, asthma symptoms, and reliance on beta2-agonists for relief. These benefits were achieved with few side effects. Suplatast tosilate may allow a reduction of steroid dose in patients with steroid-dependent asthma.

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Telomere Length and Childhood Stress Don’t Always Correlate
  3. Optogenetic Therapies Move Closer to Clinical Use
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech